Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis

Studies comparing the effects of natalizumab and fingolimod in relapsing–remitting multiple sclerosis (RRMS) are limited. We aimed to compare natalizumab and fingolimod effects on clinical, neuropsychological, and MRI measures in RRMS patients after 2 years of treatment. RRMS patients starting natal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurotherapeutics
Main Authors: Preziosa, Paolo, Rocca, Maria A., Riccitelli, Gianna C., Moiola, Lucia, Storelli, Loredana, Rodegher, Mariaemma, Comi, Giancarlo, Signori, Alessio, Falini, Andrea, Filippi, Massimo
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007466/
https://ncbi.nlm.nih.gov/pubmed/31452082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00781-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados